• OPEN AN ACCOUNT
Indian Indices
Nifty
24,836.30 225.20
(0.92%)
Sensex
80,983.31 715.69
( 0.89%)
Bank Nifty
55,347.95 712.10
( 1.30%)
Nifty IT
33,905.20 250.10
( 0.74%)
Global Indices
Nasdaq
46,462.48 43.58
(0.09%)
Dow Jones
6,731.82 22.36
(0.33%)
Hang Seng
44,630.54 -302.09
(-0.67%)
Nikkei 225
9,446.43 96.00
(1.03%)
Forex
USD-INR
88.80 0.09
(0.10%)
EUR-INR
104.21 0.20
(0.19%)
GBP-INR
119.35 0.19
(0.16%)
JPY-INR
0.60 0.00
(0.53%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
345.7486895
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
15.09
104013.74
EPS(TTM)
Face Value()
Div & Yield %
82.59
1
0.64
 

As on: Oct 01, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,246.25 22.55 247173 15.09
Stock Price Details
Open Price() 1,225.45
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,250.00
Today's Low () 1,225.45
52-Week High () 1404.6
152-Week Low () 1025.9
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.64
Eps 82.59
Book Value 345.7486895
Market Cap (.Cr) 104,013.74
Face Value 1
Market Lot 1
AGM Date Jul
Book Closure Date Jul
ISIN No. INE089A01031


News
Dr Reddys Laboratories Ltd drops for fifth straight session
Dr Reddys Laboratories schedules board meeting
Dr Reddys Laboratories Ltd - Dr. Reddys Laboratories Limited - Trading Window
Dr Reddys Laboratories Ltd - Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ending On September 30 2025
Dr Reddys Laboratories Ltd - Closure of Trading Window
Dr Reddys Laboratories Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
Dr Reddys Laboratories Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dr Reddys Laboratories Ltd - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
Dr Reddys Laboratories Ltd - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Dr Reddys Lab launches novel molecule, Tegoprazan
More
Corporate Details
Incoporation Year   : 1984
Chairman : K Satish Reddy
Bussiness Group : Dr. Reddy's
Registered Office
Dr Reddys Laboratories Ltd
8-2-337 Road No 3,
Banjara Hills,
Hyderabad,
Telangana-500034
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-40-49002900
Fax:91-40-49002999
Fax:91-22-66317458
E-Mail : shares@drreddys.com; mail@drreddys.com
URL : http://www.drreddys.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 100
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Shariah 50
  • bse carbonex
  • NIFTY
  • CNX 500
  • CNX 100
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi